Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

US drug maker <keyword id="44612" type="General" weightage="20" keywordseo="pfizer" source="Orion">Pfizer</keyword>'s Covid-19 vaccine is likely to get authorization for providing vaccines to children aged between 5 to 12 by October, according to Scott Gottlieb, former head of the Food and Drug Administration (FDA). Currently of the three Covid-19 vaccines used in the US, only the Pfizer-BioNTech vaccine has been granted the emergency use authorisation for children aged 12 and older. Pfizer along with Moderna and Johnson and Johnson are conducting clinical trials to evaluate the safety and efficacy of the vaccines in children under 12. Results of the Pfizer vaccine for children are expected in September. "Pfizer will be in a position to file data with the FDA at some point next month, and then submit its application to expand its emergency use authorisation for its vaccine in children 5 years and older as early as October," Gottlieb was quoted as saying in an interview on CBS News on Sunday. "The agency (FDA) will be in a position to make an authorisation, I believe, at some point, late fall, probably early winter. "And probably they're going to base their decision on what the circumstances around the country are, and what the urgency is to get a vaccine for kids," Gottlieb, who is also a member of Pfizer's board of directors, told CBC News. Pfizer has also been conducting clinical trials of its Covid-19 shot in children ages 2 and older. The results will be available in November. If the FDA authorises Pfizer's vaccine in kids between the ages of 5 and 11 in November or early December, "that, again, puts you on a timeframe that you could start rolling out these vaccinations before the end of the year", Gottlieb noted. Vaccinating younger children against Covid would be crucial as the highly contagious Delta variant is driving cases, particularly among the children. According to Gottlieb, there are roughly 300 kids being hospitalised each day with Covid-19, and infection rates among children have spiked with schools reopening. The two "best things" schools can do, Gottlieb said, is testing students twice a week and keeping them in geographic or social pods to cut down on intermingling among the full student body. Gottlieb also advocated for students to wear face masks and schools to improve ventilation, as well as vaccinated those who are currently eligible. SEE ALSO <a href="https://www.businessinsider.in/science/health/news/mukesh-ambanis-reliance-life-sciences-gets-approval-to-conduct-trials-for-its-covid-19-vaccine/articleshow/85677741.cms">Mukesh Ambani-owned Reliance Life Sciences' COVID-19 vaccine — here's all we know so far</a> <a href="https://www.businessinsider.in/business/auto/news/tata-motors-is-the-casualty-of-jlr-struggling-due-to-the-global-chip-shortage-and-a-lacklustre-ev-vision/articleshow/85652897.cms">Tata Motors is paying the price because Jaguar Land Rover has been slow in the EV race</a>

Pfizer's COVID-19 vaccine may be authorised for kids aged 5-12 by October, says company's board member

<ul class="summary-list"><li><keyword id="9148385" type="UNKNOWN" weightage="60" keywordseo="sinovac">Sinovac</keyword>'s COVID-19 <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword> CoronaVac was 50.7% effective against symptomatic COVID-19 in a <keyword id="6355226" type="LOCATION" weightage="60" keywordseo="brazil">Brazil</keyword> trial.</li><li>The benchmark for a vaccine worth using is 50%.</li><li>The trial of Sinovac's CoronaVac vaccine tested the shot in more than 12,000 <keyword id="6354750" type="UNKNOWN" weightage="60" keywordseo="health">health</keyword> workers.</li></ul>The COVID-19 vaccine from Chinese biotech Sinovac is about 50% effective at preventing symptomatic <keyword id="1754604" type="PERSON" weightage="60" keywordseo="coronavirus">coronavirus</keyword>, <a href="https://www.businessinsider.com/chinese-health-official-covid19-vaccines-dont-have-high-protection-rates-2021-4" target="_blank" rel="noopener">a late-stage trial in Brazil showed.</a>The two-dose CoronaVac vaccine was safe and 50.7% effective against symptomatic COVID-19, Sinovac's Brazilian partner, Butantan, said <a href="https://poseidon01.ssrn.com/delivery.php?ID=029123122124116028113069105010095086046017064042000030023121065104123100009110024098059042125003033000013011028066020085076089045061037061029013102123099072096092112041086012111003096026070120067121111021025091067025122108023070092113079113019101024117&amp;EXT=pdf&amp;INDEX=TRUEDEX=TRUE" target="_blank" rel="noopener">in a preprint posted Sunday</a>, confirming <a href="https://www.businessinsider.com/sinovac-coronavirus-vaccine-effective-covid-brazil-trial-2021-1" target="_blank" rel="noopener">top-line results announced by the group</a> in a press release in January.The World Health Organization (WHO) <a href="https://www.who.int/blueprint/priority-diseases/key-action/WHO_Target_Product_Profiles_for_COVID-19_web.pdf">said April 2020</a> that a vaccine that was 50% effective in trials was worth using.Butantan said that "efficacy to prevent any symptomatic COVID-19 started at 50.7% and became more extensive as disease severity increased." The study authors found CoronaVac was 100% effective against severe COVID-19, but the number of cases was too small for them to be confident in the figure.The authors noted higher efficacy with more time between doses - 21 days rather than 14 - but didn't provide exact figures.The study tested the vaccine in more than 12,000 health workers across 16 sites in Brazil.Read more: <a href="https://www.businessinsider.com/coronavirus-vaccine-tracker-top-covid-shots-to-watch-in-2021" target="_blank" rel="noopener">COVID-19 Vaccine Tracker: AstraZeneca's shot proves safe and effective, and is headed to the FDA</a>The vaccine was generally well tolerated. Some people had pain at the injection site and muscle aches.The study hasn't been scrutinized by experts in a peer review.Despite the positive results, George Fu Gao, head of the Chinese Center for Disease Prevention and Control, said Saturday that the vaccine <a href="https://www.businessinsider.com/chinese-health-official-covid19-vaccines-dont-have-high-protection-rates-2021-4" target="_blank" rel="noopener">wasn't as good as expected.</a>In Turkey, CoronaVac was <a href="https://www.reuters.com/article/health-coronavirus-turkey-sinovac-int-idUSKBN2AV18P" target="_blank" rel="noopener">83.5% effective</a> in a study of more than 10,000 participants aged between 19 and 59. The Brazil study included people over 60 - about 5% of participants - and took place in a country where coronavirus cases are surging.Brazil has more than 330 new cases per million every day, compared with 206 in the US and 22 in the UK, <a href="https://ourworldindata.org/covid-cases">according to Oxford University's Our World in Data.</a>Butantan's study doesn't tell us whether or not CoronaVac works against P.1, a variant that has spread in the country: Data collection ended on December 16, and P.1 was first detected in Brazil on December 4.If it turned out to be variants making CoronaVac less effective, booster shots made by mixing the vaccine with others could help, Gao said.The vaccine costs about $30 per dose, <a href="http://www.globaltimes.cn/content/1210093.shtml" target="_blank" rel="noopener">according to Chinese state media</a>, and can be stored at normal fridge temperatures, so it could be a useful option for low- and middle-income countries struggling to secure vaccines. The <a href="https://www.reuters.com/article/health-coronavirus-astrazeneca-idUSKBN2BW2D1" target="_blank" rel="noopener">WHO said Friday</a> that low income countries had received just 0.2% of the 700 million jabs administered worldwide.More than 180 million CoronaVac doses have already been sent to 30 low-and-middle income countries, including Brazil, Chile, and the Philippines, according to Butantan.

China's Sinovac vaccine is 50.7% effective against COVID-19, just reaching the threshold to be a vaccine worth using, a major trial showed

<ul class="summary-list"><li>The first man to get <keyword id="44612" type="CITY" weightage="60" keywordseo="Pfizer">Pfizer</keyword>'s <keyword id="1754604" type="PERSON" weightage="60" keywordseo="coronavirus">coronavirus</keyword> <keyword id="24209" type="PERSON" weightage="60" keywordseo="vaccine">vaccine</keyword> out of trials in England was called William Shakespeare.</li><li>The UK approved the vaccine last week, and begun inoculating vulnerable people in the Midland county Warwickshire on Tuesday.</li><li>Shakespeare, 81, and his literary namesake were both born in the county, and the internet wasted no time cracking jokes.</li><li>Adaptions of the titles of Shakespeare's plays were popular, including "The Taming of the Flu" and "The Two Gentlemen of Corona."</li></ul>One of the first people injected with Pfizer and BioNTech's coronavirus vaccine outside trials in England was called William Shakespeare.The UK became the first country to <a href="https://www.businessinsider.com/pfizer-and-biontech-covid-19-vaccines-approved-by-uk-regulator-2020-11">approve the vaccine on Wednesday last week</a>, and began administering it to vulnerable people on Tuesday morning.The first recipient was Margaret Keenan, a 90-year-old grandmother, who <a href="https://www.businessinsider.com/coronavirus-vaccine-uk-grandma-margaret-keenan-pfizer-first-2020-12">was injected at 6:31 a.m. local time at University Hospital in Coventry</a>, Warwickshire.Moments later, 81-year-old William Shakespeare became the first man to be inoculated, <a href="https://www.bbc.co.uk/news/live/uk-england-birmingham-55192920">the BBC said.</a>Shakespeare, who like the 16th century bard, grew up in Warwickshire, said he was "pleased" and praised the staff at the hospital, which is just 20 miles from Stratford-upon-Avon, the birthplace of the famous playwright and poet.The irony was not lost on the internet, which seized on the coincidence.One popular comment described the moment as "The Taming of the Flu" - a play on the title of Shakespeare's comedy "The Taming of the Shrew."Another described 81-year-old Shakespeare as one of "The Two Gentlemen of Corona."Another popular joke pondered that if Keenan, the first to get the jab, was patient 1A, then did that make Shakespeare "Patient 2B or not 2B?"Some jokes went even deeper into literary history."Actually I heard the second person to get the vaccine was Christopher Marlowe but William Shakespeare took all the credit," wrote Twitter user Tiernan Douieb, referring to the theory that some of Shakespeare's plays were written by his contemporaries.One joke even spanned literary history and modern medicine."Exit, pursued by Bayer," read the comment, combining the famous stage direction from "The Winter's Tale" with the German pharma giant.The UK had preordered around 40 million doses of the Pfizer vaccine, which is administrated in two separate shots.

The first man to receive Pfizer's COVID-19 vaccine outside clinical trials is an Englishman named William Shakespeare, and the internet is having a field day

<ul class="summary-list"><li>In the US, the age minimum to receive a COVID-19 vaccines is 5.</li><li>US officials say a <keyword id="11894310" type="UNKNOWN" weightage="60" keywordseo="vaccine" source="Orion">vaccine</keyword> for younger <keyword id="11903370" type="UNKNOWN" weightage="60" keywordseo="kids" source="Orion">kids</keyword> is on its way, pending trial data.</li></ul>It's been nearly six months since the US Centers for Disease Control and Prevention <a href="https://www.businessinsider.com/fda-authorizes-pfizers-covid-19-vaccine-for-younger-kids-2021-10">authorized</a> Pfizer's <keyword id="11896806" type="UNKNOWN" weightage="60" keywordseo="covid-19-vaccine" source="Orion">COVID-19 vaccine</keyword> for everyone as young as 5 years old.But officials are still holding off on vaccinating younger kids until Pfizer and Moderna conclude their trials testing baby doses for kids aged six months to 4 years old. Europe, meanwhile, is squarely <a href="https://www.euronews.com/next/2022/02/25/covid-vaccine-for-children-who-in-europe-is-leading-the-race">focused on vaccinating kids over 5 years old</a> — with the exception of Sweden, which <a href="https://www.reuters.com/world/europe/sweden-decides-against-recommending-covid-vaccines-kids-aged-5-12-2022-01-27/">decided against</a> recommending shots for kids under 11 years old.In fact, there are just seven countries in the world where younger kids are being vaccinated against COVID-19. Here's what we know about them:<h2>China began vaccinating younger kids before the Omicron surge</h2>China's COVID-19 cases have reached new highs this month, as the Omicron variant has <a href="https://www.reuters.com/world/china/chinas-xi-says-sticking-tough-covid-curbs-will-bring-victory-2022-04-14/">spread swiftly and led to lockdowns in Shanghai</a>. Before the latest variant turned the tide, China's top priority was rolling out vaccines to its youngest citizens. About 84 million children had received two shots of the Sinovac vaccine by November 2021, when China's National <keyword id="11894571" type="UNKNOWN" weightage="60" keywordseo="health" source="Orion">Health</keyword> Commission issued an <a href="http://www.news.cn/english/2021-11/13/c_1310309137.htm">update</a>.Kids aged 3 and older can get the Sinovac or Sinopharm shots. Vaccination for children is voluntary, <a href="https://www.bloomberg.com/news/articles/2021-11-15/china-aims-to-vaccinate-all-kids-aged-three-and-over-by-year-end">officials said</a>.Vaccine clinics opened in schools around the country in the fall, although some regions are seeing a <a href="https://www.usnews.com/news/education-news/articles/2022-03-14/lockdowns-school-closures-return-to-mainland-china">return to online class and work</a> in recent months. <h2>Hong Kong lowered the age limit for vaccine eligibility as Omicron set in</h2>In Hong Kong, authorities recommended vaccinating children aged 3 and up in <a href="https://www.reuters.com/markets/asia/hong-kong-authorises-sinovac-vaccine-children-aged-3-17-2021-11-20/">November 2021</a>. But it wasn't until <a href="https://abcnews.go.com/Health/wireStory/hong-kong-vaccinate-year-olds-amid-covid-19-82874453">February this year</a> that the age limit was lowered, and toddlers started receiving doses of Sinovac, the vaccine manufactured in China.With the Omicron variant already causing new spikes in case counts around the world, parents were anxious to get their children vaccinated as soon as possible, the <a href="https://www.scmp.com/video/coronavirus/3167109/hong-kong-parents-rush-get-kids-vaccinated-daily-covid-19-cases-rise">South China Morning Post</a> reported February 15.<h2>Bahrain approved one of the Chinese-made vaccines for young kids</h2>Bahrain signed off on the Sinopharm vaccine, which is also made in China, in <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/bahrain-approves-sinopharm-vaccine-children-aged-3-11-2021-10-26/">October 2021</a>.Now, children aged 3-11 are eligible to get the Sinopharm vaccine in Bahrain.<h2>Chile rolled out Sinovac to young kids, but says it hasn't held up well against Omicron</h2>In December, health officials in Chile announced a plan to vaccinate all children ages 3-5.Based on studies in China, the Sinovac vaccine had a higher rate of adverse reactions in older children than in younger ones, which <a href="https://www.efe.com/efe/english/world/chile-starts-vaccinating-kids-ages-3-5/50000262-4692233">officials said</a> was a factor in their decision to authorize the shots.Chilean children can get Sinovac's COVID-19 vaccine, known in the country as CoronaVac, but early data suggests it might not be very helpful in the fight against Omicron. A Chile-based <a href="https://www.researchsquare.com/article/rs-1440357/v1">study</a> (not yet peer-reviewed) of the vaccine found it was 38.2% effective in preventing infections in kids ages 3-5 during the Omicron wave.The vaccine was more effective when it came to preventing pediatric hospitalizations (64.5%) and deaths (69%).<h2>Argentina authorized Sinopharm for children age 3 years old and up</h2>Argentine health officials authorized the Sinopharm vaccine for emergency use in children ages 3 and up in early October 2021, with the intention of vaccinating everyone who is eligible by 2022.Health ministry data from January showed 46.3% of children between 3 and 11 were fully vaccinated, while 69.5% had gotten at least their first dose, according to <a href="https://www.laprensalatina.com/argentina-launches-vax-campaign-to-get-kids-back-to-in-person-classes/">EFE</a>. <h2>Cuba was the first country in the world to start vaccinating kids as young as 2</h2>Cuba started out with ambitious targets for its vaccine rollout. The country aimed to vaccinate <a href="https://www.reuters.com/world/americas/cuba-aims-fully-inoculate-90-residents-against-covid-19-by-december-2021-10-01/">90% of its population</a> by December 2021 using Cuban-made vaccines: Abdala, Soberana-2, and Soberana-plus.Now, more than 87% of the Cuban population is fully vaccinated, and that includes young children. In <a href="https://www.nytimes.com/2021/09/14/world/americas/cuba-children-vaccine.html">October 2021</a>, the country authorized two of its vaccines — Soberana-2 and Soberana-plus — for kids as young as two years old. Cuba has a reputation for high quality medicine, and researchers behind the nation's vaccines <a href="http://www.cubadebate.cu/noticias/2021/12/19/programa-materno-infantil-prioridad-para-la-salud-publica-aun-ante-la-covid-19/">say</a> they recorded no notable adverse effects in their clinical trials of young kids.However, international researchers have voiced skepticism."None of the results have been published in peer-reviewed journals, so it's hard to discuss," Dr. Jon K Andrus, a professor of public health at George Washington University and a former immunization program director at the Pan American Health Organisation, told the <a href="https://www.theguardian.com/world/2022/feb/01/cuba-leads-world-vaccinating-children">Guardian</a>.<h2>Venezuela follow shortly after</h2>In November, <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/venezuela-begins-vaccinating-2-year-old-children-with-cuban-doses-vice-president-2021-11-08/">Venezuela authorized</a> the emergency use of Soberana-2, one of Cuba's COVID-19 vaccines, in children aged 2-11. By late March, the Venezuelan government <a href="https://www.efe.com/efe/america/sociedad/el-73-de-menores-venezolanos-estan-vacunados-contra-la-covid-dice-ministra/20000013-4771624">said</a> 73% of kids had received a dose of the vaccine.

The 7 countries where kids under 5 years old are eligible for COVID-19 vaccines, and how the roll-outs are shaping up

After school and playtime, there are still some hours in your child's day for other activities. Instead of the TV or video games, you could engage them in some educational games that will help them revise what they've learnt in school as well as pick up some new concepts. These games are fun so your child will not feel like they are studying. Check them out. <bulletContentEmbed name="B01MTNA7I0" columns="1"><bulletContentHeading name="B01MTNA7I0_head"><div type="image" title="Increase Knowledge" msid="90912574" hostid="261"></div></columnHeadThumb>B01MTNA7I0</columnHeadTitle></columnHead></bulletContentHeading><bulleteContentBody name="B01MTNA7I0_body"><bulletContentRow name="B01MTNA7I0_8003340296113879"><bulletContentRowHeading><bulletContentRowHead col="1">Einstein Box</bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">This is a great kit that will teach kids about science, geography and language. It will improve their memory and open their minds to reason and logic. There are 3 books as well as 3 activity sets, making it a great blend of theory and practical knowledge. It comes with a wipe-clean pen so they can erase and do the activities again.</bulletContentRowCell></bulletContentRowBody></bulletContentRow><bulletContentRow name="B01MTNA7I0_8534867673268718"><bulletContentRowHeading><bulletContentRowHead col="1"></bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">There are 3 books as well as 3 activity sets, making it a great blend of theory and practical knowledge.</bulletContentRowCell></bulletContentRowBody></bulletContentRow></bulleteContentBody></bulletContentEmbed> <bulletContentEmbed name="8193752333" columns="1"><bulletContentHeading name="8193752333_head"><div type="image" title="Learn origami and clay modelling" msid="90439526" hostid="261"></div></columnHeadThumb>8193752333</columnHeadTitle></columnHead></bulletContentHeading><bulleteContentBody name="8193752333_body"><bulletContentRow name="8193752333_8843906914106144"><bulletContentRowHeading><bulletContentRowHead col="1">Activity Books Collection for Early Learning</bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">There are 8 activity books in this set. All you have to do is provide your kids with the material required to do the activities. They can learn origami and clay modelling. The other activities involve solving puzzles, colouring, shading, and learning about fruits and vegetables.</bulletContentRowCell></bulletContentRowBody></bulletContentRow><bulletContentRow name="8193752333_6813197601566535"><bulletContentRowHeading><bulletContentRowHead col="1"></bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">The other activities involve solving puzzles, colouring, shading, and learning about fruits and vegetables.</bulletContentRowCell></bulletContentRowBody></bulletContentRow></bulleteContentBody></bulletContentEmbed> <bulletContentEmbed name="B098RRLH42" columns="1"><bulletContentHeading name="B098RRLH42_head"><div type="image" title="Flash cards with puzzles" msid="90439613" hostid="261"></div></columnHeadThumb>B098RRLH42</columnHeadTitle></columnHead></bulletContentHeading><bulleteContentBody name="B098RRLH42_body"><bulletContentRow name="B098RRLH42_9846504149425810"><bulletContentRowHeading><bulletContentRowHead col="1">Matching Letter Game</bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">In this game, there's a card machine, flash cards with puzzles, and letter cubes. You can put the flash cards in the card slot and your child has to answer the questions. The answers can be formed with the letter/number cubes and places on the machine. You can then crosscheck the answer by pulling out the card.</bulletContentRowCell></bulletContentRowBody></bulletContentRow><bulletContentRow name="B098RRLH42_2157606712784772"><bulletContentRowHeading><bulletContentRowHead col="1"></bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">The answers can be formed with the letter/number cubes and places on the machine.</bulletContentRowCell></bulletContentRowBody></bulletContentRow></bulleteContentBody></bulletContentEmbed> <bulletContentEmbed name="B09KWZZJWF" columns="1"><bulletContentHeading name="B09KWZZJWF_head"><div type="image" title="Magnetic board" msid="90439687" hostid="261"></div></columnHeadThumb>B09KWZZJWF</columnHeadTitle></columnHead></bulletContentHeading><bulleteContentBody name="B09KWZZJWF_body"><bulletContentRow name="B09KWZZJWF_6026266270060265"><bulletContentRowHeading><bulletContentRowHead col="1">Pelikas Toyz Brain Games for Kids</bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">This game has a magnetic board and a number of puzzle pieces in the form of various shapes. There's an instruction manual that has loads of images that can be formed with those pieces. Your child has to figure out how. It's a fun game that brings out the logic and creativity in children.</bulletContentRowCell></bulletContentRowBody></bulletContentRow><bulletContentRow name="B09KWZZJWF_3520482128183396"><bulletContentRowHeading><bulletContentRowHead col="1"></bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">It's a fun game that brings out the logic and creativity in children.</bulletContentRowCell></bulletContentRowBody></bulletContentRow></bulleteContentBody></bulletContentEmbed> <bulletContentEmbed name="B09G2ZKBG7" columns="1"><bulletContentHeading name="B09G2ZKBG7_head"><div type="image" title="Memory skills and spellings" msid="90439788" hostid="261"></div></columnHeadThumb>B09G2ZKBG7</columnHeadTitle></columnHead></bulletContentHeading><bulleteContentBody name="B09G2ZKBG7_body"><bulletContentRow name="B09G2ZKBG7_4541112647352460"><bulletContentRowHeading><bulletContentRowHead col="1">HUNK SHOPPERS See and Spell <keyword id="9699246" type="General" weightage="20" keywordseo="learning-toys" source="Orion">Learning Toys</keyword></bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">Your preschooler has just about started to learn words and their spellings, making this game an ideal one for them. There are cardboard strips that have the image of an object and the name written next to it. Your child has to identify the object, pronounce the name correctly, and then search for the letters to match the printed letters. It's a great way to help them with memory skills and spellings.</bulletContentRowCell></bulletContentRowBody></bulletContentRow><bulletContentRow name="B09G2ZKBG7_8321687985742228"><bulletContentRowHeading><bulletContentRowHead col="1"></bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">Your child has to identify the object, pronounce the name correctly, and then search for the letters to match the printed letters. It's a great way to help them with memory skills and spellings.</bulletContentRowCell></bulletContentRowBody></bulletContentRow></bulleteContentBody></bulletContentEmbed> <bulletContentEmbed name="9388144104" columns="1"><bulletContentHeading name="9388144104_head"><div type="image" title="Observation and memory skills." msid="90439890" hostid="261"></div></columnHeadThumb>9388144104</columnHeadTitle></columnHead></bulletContentHeading><bulleteContentBody name="9388144104_body"><bulletContentRow name="9388144104_6118543845826795"><bulletContentRowHeading><bulletContentRowHead col="1">My First 500 Words</bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">This picture book has everything that you need for early learning. Whatever you're trying to teach your child, you'll have a fun picture to support it in this book. Teach them letters, numbers, animals, shapes, birds, fruits, vegetables, toys, and much more. There are over 500 photos that will help in improving your child's observation and memory skills.</bulletContentRowCell></bulletContentRowBody></bulletContentRow><bulletContentRow name="9388144104_9742149107841534"><bulletContentRowHeading><bulletContentRowHead col="1"></bulletContentRowHead></bulletContentRowHeading><bulletContentRowBody><bulletContentRowCell col="1">Teach them letters, numbers, animals, shapes, birds, fruits, vegetables, toys, and much more.</bulletContentRowCell></bulletContentRowBody></bulletContentRow></bulleteContentBody></bulletContentEmbed>

Best learning toys for 5-year old kids

<ul><li>Early trials show that Chinese COVID vaccine, CoronaVac triggers a quick immune response</li><li>Vladimir Putin calls for a joint effort by the BRICS countries on the development of the coronavirus vaccines, suggesting that Sputnik V vaccine could be produced in China and India.</li><li>Moderna’s COVID-19 vaccine shows over 94% efficacy, Indian government is in talks with the US biotech giant.</li><li>Vaccine maker Bharat Biotech has started Phase III trials of Covaxin, India's first indigenous vaccine for COVID-19.</li></ul>After registering over 48 million COVID-19 infections, the World Health Organisation is <a href="https://www.livemint.com/science/health/who-expects-to-see-covid-19-vaccine-by-end-of-2020-at-earliest-11602548070399.html">finally expecting</a> a COVID-19 vaccine by the end of 2020 or early 2021. It takes a decade or two to design, test, and launch an effective vaccine that can protect billions of people from diseases. However, COVID-19 has forced researchers to fast-track the vaccine making process. Here’s a look at COVID-19 vaccine updates from around the world — Early trials show that Chinese COVID vaccine, CoronaVac triggers a quick immune response Preliminary trial results show that Sinovac Biotech’s COVID-19 vaccine CoronaVac triggers a quick immune response. However the level of antibodies produced was lower than in people who recovered from the disease, <a href="https://in.reuters.com/article/us-health-coronavirus-sinovac/sinovacs-covid-19-vaccine-induces-quick-immune-response-study-idUSKBN27X354">Reuters </a>reported. The research that was published in a Lancet study shows that the vaccine is safe and could provide sufficient protection. Russian President: Sputnik V vaccine could be produced in India and China Russian President Vladimir Putin called for a joint effort by the BRICS countries on the development of the coronavirus vaccines as he suggested that Russia's Sputnik V vaccine against COVID-19 could be produced in China and India, which are members of the five-nation bloc. "We believe it is important to speed up the establishment of the centre for development and research of BRICS vaccines, which we agreed to do two years ago, upon the initiative of our South African friends," Putin said while addressing the 12th BRICS summit via videoconferencing. Moderna’s COVID-19 vaccine shows over 94% efficacy, Indian government is in talks with the US biotech giant. India is in dialogue with the US-based biotech giant Moderna over the progress in the clinical trials of its coronavirus vaccine candidate, which the firm said has shown 94.5 percent efficacy, official sources said on Monday. "We are in dialogue not only with Moderna, but also with Pfizer, Serum Institute, Bharat Biotech and Zydus Cadila over the progress of the clinical trials of each of the vaccine candidates and where their vaccines stand in terms safety, immunogenicity and efficacy, and regulatory approvals," a source said. On Monday, <a href="https://www.businessinsider.in/science/health/news/moderna-says-its-coronavirus-vaccine-is-94-5-effective-against-covid-19-a-crucial-victory-in-the-fight-against-the-pandemic/articleshow/79247349.cms">Moderna </a>said that its vaccine candidate against COVID-19 was found to have an efficacy of 94.5 percent. Bharat Biotech begins phase III trials for Covaxin Vaccine maker <a href="https://www.businessinsider.in/india/news/indias-first-vaccine-candidate-covaxins-phase-3-trials-begin/articleshow/79249854.cms">Bharat Biotech</a> has started Phase III trials of Covaxin, India's first indigenous vaccine for COVID-19. The Phase III trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). According to a <a href="https://in.reuters.com/article/health-coronavirus-india-vaccine/exclusive-india-made-covid-19-vaccine-could-be-launched-as-early-as-february-government-scientist-idINKBN27L0WU">Reuters report</a>, Bharat Biotech COVAXIN could be launched as early as February as studies have so far shown it is safe and effective. Bharat Biotech had earlier hoped to launch it only in the second quarter of next year. EU signs a deal with German biotech firm CureVac According to a <a href="https://in.reuters.com/article/health-coronavirus-eu-curevac/eu-to-okay-deal-with-curevac-for-supply-of-up-to-405-million-covid-vaccines-idINKBN27W1Z5">Reuters </a>report, the European Union has signed a deal with German biotech firm CureVac to buy upto 405 million doses of its potential COVID-19 vaccine. European Commission President Ursula von der Leyen said this deal takes the total supplies secured by the bloc to nearly 2 billion doses. The deal with CureVac follows EU supply agreements with AstraZeneca, Johnson &amp; Johnson, Sanofi, and Pfizer for a combined 1.4 billion doses of their potential vaccines Pfizer’s COVID vaccine is 90% effective The latest data from t<a href="https://www.businessinsider.in/science/health/news/pfizers-covid-19-vaccine-is-90-effective-in-preventing-coronavirus-in-those-who-havent-been-infected-ever-before/articleshow/79130097.cms">he US pharmaceutical giant Pfizer</a> and German biotech firm BioNTech late-stage vaccine trial shows that their COVID-19 vaccine is <a href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against">90% more effective</a> in preventing infection if a person has never come in contact with it before. This means that those who get the vaccine will be protected within 28 days of the first dose — and there is only a two-dose schedule. Eli Lilly gets USFDA nod for COVID antibody drug in emergency use The US Food and Drug Administration (USFDA) on Monday has granted emergency approval to a synthetic <a href="https://www.bloombergquint.com/onweb/eli-lilly-covid-19-antibody-therapy-gets-emergency-fda-clearance">antibody treatment against COVID-19 developed by Eli Lilly</a>. The drug was shown to reduce the risk of hospitalization and emergency room visits. The drug, Bamlanivimab, is the first major drug to be approved that was designed specifically against the coronavirus. SEE ALSO:<a href="https://www.businessinsider.in/science/health/news/moderna-says-its-coronavirus-vaccine-is-94-5-effective-against-covid-19-a-crucial-victory-in-the-fight-against-the-pandemic/articleshow/79247349.cms" data-type="tilCustomLink"> Moderna says its coronavirus vaccine is 94.5% effective against COVID-19, a crucial victory in the fight against the pandemic</a> <a href="https://www.businessinsider.in/stock-market/news/dow-soars-375-points-to-near-record-as-modernas-vaccine-update-boosts-investor-optimism/articleshow/79249468.cms" data-type="tilCustomLink">Dow soars 450 points to new record as Moderna's vaccine update boosts investor optimism</a>

COVID-19 vaccine latest updates: Sinovac’s CoronaVac safe, early trial results show that vaccine triggers immune response

<ul><li>You can now download your <keyword id="8971762" type="UNKNOWN" weightage="20" keywordseo="covid-19-vaccination">COVID-19 vaccination</keyword> certificate on <keyword id="790242" type="COMPANY" weightage="20" keywordseo="WhatsApp">WhatsApp</keyword>.</li><li>You can follow the simple steps given below to download the certificate on WhatsApp.</li><li>You can access the certificate on the MyGov Corona Helpdesk bot.</li></ul>The COVID-19 vaccination certificate has become an essential document for travelling between states and countries. Now a new service introduced by the government allows users to access their COVID-19 vaccine certificates on WhatsApp. The facility is available via the MyGov Corona Helpdesk bot which was introduced last year to help people find nearby vaccination centres and other information regarding the coronavirus pandemic. Earlier, you could only access and download the COVID-19 vaccination certificate on the <a href="https://www.cowin.gov.in/">COWIN</a> portal. If you are a vaccinated person looking to download the COVID-19 vaccine certificate on WhatsApp, you can follow the simple instructions given below. Here’s how you can download the COVID-19 vaccination certificate <ol><li>You will need to first save the number “+91 9013151515” on your phone.</li><li>Then go to the WhatsApp application and search for the MyGov Corona Helpdesk.</li><li>You can also access the helpdesk on WhatsApp by clicking <a href="https://api.whatsapp.com/send/?phone=919013151515&amp;text=Hi&amp;app_absent=0">here</a>.</li><li>Open the chatbox and send “COVID certificate” or “Download certificate”.</li><li>You will get a six-digit OTP on the registered mobile number, which will have to be entered within 30 seconds.</li><li>You will be able to view the names of all users registered to the mobile number on the COWIN portal.</li><li>The bot will ask you to select the person whose certificate you wish to download.</li><li>You will have to type in and send the number associated with the person’s name.</li><li>The bot will then send the certificate of the person selected in pdf format.</li><li>The certificate can be downloaded and saved or printed for future references.</li><li>You can follow the same steps to download certificates for other users associated with the mobile number.</li></ol>If you are yet to get yourself registered for vaccination, you can do it on the COWIN portal. You can look for vaccination centres and availability nearby using the <a href="https://www.mygov.in/covid-19/">MyGov Corona </a>Helpdesk. ALSO READ: <a href="https://www.businessinsider.in/india/news/covid-19-vaccine-how-to-register-yourself-on-cowin-and-aarogya-setu-apps-if-you-are-18-plus/articleshow/82242963.cms">How to register from Aarogya Setu app and cowin website if you are 18 plus</a> <a href="https://www.businessinsider.in/tech/news/how-store-your-covid-card-on-your-android-device/articleshow/84013999.cms">Google now lets you store Covid vaccine certificates and test info on Android device</a>

Here’s how to get COVID-19 vaccination certificate on WhatsApp

<ul><li>Feluda, the paper strip test for COVID-19 diagnosis is set to be launched in Delhi today, according to a report. </li><li>Spain approves phase three trials of Johnson &amp; Johnson COVID-19 vaccine.</li><li>Pfizer’s COVID-19 vaccine is 95% effective, final study shows</li><li>Early trials show that Chinese COVID vaccine, CoronaVac triggers a quick immune response</li></ul>The latest wave of COVID-19 infections across the world has taken the global tally of cases over the 56 million mark. Deaths in the US have surpassed 2,50,000, a new grim milestone amid an unabated resurgence in the worst hit country in the world, according to Johns Hopkins University. India stands second with over 89 lakh cases. There has been a glimmer of hope with three global vaccine candidates showing over 90% efficacy rate in the last one week. Here’s a look at COVID-19 vaccine updates from around the world — Spain approves phase three trials of Johnson &amp; Johnson COVID-19 vaccine Spain has authorised phase 3 trials of the vaccine being developed by Johnson and Johnson-owned Janssen Pharmaceutica, <a href="https://in.reuters.com/article/us-health-coronavirus-vaccine-spain/spain-authorises-phase-iii-trial-of-johnson-johnson-covid-19-vaccine-idINKBN27Y16V">Reuters </a>reported. This is the first vaccine candidate which will enter phase 3 trials in the country and will be conducted in nine hospitals. Feluda paper strip test to be launched in Delhi Feluda, the paper strip test for COVID-19 diagnosis is set to be launched in India’s national capital, Delhi, today, according to a report by <a href="https://www.hindustantimes.com/india-news/feluda-test-kit-set-to-hit-the-market-on-thursday/story-r9MpXIgENV4s3auJAEySMK.html">Hindustan Times.</a> The indigenously developed testing kit based on a gene editing technology called CRISPR was launched by the Tata Group earlier this month. Reports suggest that this paper strip test is expected to be cheaper than the current RT-PCR test. The <keyword id="9073143" type="UNKNOWN" weightage="20" keywordseo="feluda-test">Feluda test</keyword> had shown 96% sensitivity and 98% specificity in tests; and was approved for use by the Indian Council of Medical Research in September. Pfizer’s COVID-19 vaccine is 95% effective, final study shows Global drug makers Pfizer and BioNTech said that their COVID-19 vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial, including in people aged over 65 years, paving the way for the companies to apply for emergency authorisation from US regulators within days. Early trials show that Chinese COVID vaccine, CoronaVac triggers a quick immune response Preliminary trial results show that Sinovac Biotech’s COVID-19 vaccine CoronaVac triggers a quick immune response in healthy volunteers aged 18 to 59 years. According to the findings of the phase 1/2 randomised clinical trial, the vaccine candidate could induce an antibody response in participants within 28 days of the first immunisation, by giving two doses 14 days apart. However the level of antibodies produced was lower than in people who recovered from the disease, <a href="https://in.reuters.com/article/us-health-coronavirus-sinovac/sinovacs-covid-19-vaccine-induces-quick-immune-response-study-idUSKBN27X354">Reuters </a>reported. The research that was published in a Lancet study shows that the vaccine is safe and could provide sufficient protection. Russian President: Sputnik V vaccine could be produced in India and China Russian President Vladimir Putin called for a joint effort by the BRICS countries on the development of the coronavirus vaccines as he suggested that Russia's Sputnik V vaccine against COVID-19 could be produced in China and India, which are members of the five-nation bloc. "We believe it is important to speed up the establishment of the centre for development and research of BRICS vaccines, which we agreed to do two years ago, upon the initiative of our South African friends," Putin said while addressing the 12th BRICS summit via videoconferencing. Moderna’s COVID-19 vaccine shows over 94% efficacy, Indian government is in talks with the US biotech giant India is in dialogue with the US-based biotech giant Moderna over the progress in the clinical trials of its coronavirus vaccine candidate, which the firm said has shown 94.5 percent efficacy, official sources said on Monday. "We are in dialogue not only with Moderna, but also with Pfizer, Serum Institute, Bharat Biotech and Zydus Cadila over the progress of the clinical trials of each of the vaccine candidates and where their vaccines stand in terms safety, immunogenicity and efficacy, and regulatory approvals," a source said. On Monday, <a href="https://www.businessinsider.in/science/health/news/moderna-says-its-coronavirus-vaccine-is-94-5-effective-against-covid-19-a-crucial-victory-in-the-fight-against-the-pandemic/articleshow/79247349.cms">Moderna </a>said that its vaccine candidate against COVID-19 was found to have an efficacy of 94.5 percent. Bharat Biotech begins phase III trials for Covaxin Vaccine maker <a href="https://www.businessinsider.in/india/news/indias-first-vaccine-candidate-covaxins-phase-3-trials-begin/articleshow/79249854.cms">Bharat Biotech</a> has started Phase III trials of Covaxin, India's first indigenous vaccine for COVID-19. The Phase III trials, which involve 26,000 volunteers across India, are being conducted in partnership with the Indian Council of Medical Research (ICMR). According to a <a href="https://in.reuters.com/article/health-coronavirus-india-vaccine/exclusive-india-made-covid-19-vaccine-could-be-launched-as-early-as-february-government-scientist-idINKBN27L0WU">Reuters report</a>, Bharat Biotech COVAXIN could be launched as early as February as studies have so far shown it is safe and effective. Bharat Biotech had earlier hoped to launch it only in the second quarter of next year. SEE ALSO:<a href="https://www.businessinsider.in/stock-market/news/dow-tumbles-345-points-as-fresh-lockdown-measures-overshadow-vaccine-progress/articleshow/79292917.cms" data-type="tilCustomLink"> Dow tumbles 345 points as fresh lockdown measures overshadow vaccine progress</a> <a href="https://www.businessinsider.in/science/health/news/pfizers-new-covid-19-vaccine-is-95-effective-and-the-only-severe-side-effect-to-worry-about-is-fatigue-according-to-the-final-results/articleshow/79284286.cms" data-type="tilCustomLink">Pfizer's new COVID-19 vaccine is 95% effective and the only severe side-effect to worry about is fatigue, according to the final results</a>

COVID-19 vaccine latest updates: Spain approves phase III trials of J&J vaccine, Feluda test kit for COVID to be launched in Delhi

In a major shift of narrative, the government has now not disapproved the <keyword id="962031" type="PERSON" weightage="20" keywordseo="authorisation">authorisation</keyword> of <keyword id="149108" type="PERSON" weightage="20" keywordseo="Bharat-Biotech">Bharat Biotech</keyword>'s Covid vaccine to people below 18 years of age whereas earlier, it was approved for children above the age of 12 years by the Drugs Controller General of India (DCGI). A letter from the office of additional secretary at the <keyword id="83655" type="COMPANY" weightage="20" keywordseo="Union-health-ministry">union health ministry</keyword> carrying a comparative factsheet for the two Covid vaccines approved for emergency authorisation revealed that the government has "not recommended" their authorisation to people below 18 years of age. The DCGI, after approving Bharat Biotech's <keyword id="9485939" type="LOCATION" weightage="20" keywordseo="covaxin">Covaxin</keyword> for EUA, had allowed its authorization to children above 12 years of age. The document of permission to the Hyderabad-based pharmaceutical firm signed by the DCGI clearly states that "active immunization against Corona Virus Disease (Covid-19) for age above 12 years when administered in two doses interval of day 0 and day 28". At the same time, another Corona vaccine, Covishield by <keyword id="95879" type="COMPANY" weightage="20" keywordseo="Serum-Institute-of-India">Serum Institute of India</keyword> (SII), was permitted to people above 18 years of age, permission letter to the SII showed. However, when IANS approached CDSCO with the query upon this, the officials said that the provision was soon withdrawn and revised by the drug licensing authority. The sources privy to the development told IANS that this certain condition approved for Covaxin was flagged to the drug regulatory authority and soon it was rebuked. "We were flagged about the provision and soon it was revised with a condition that the vaccines would only be administered to beneficiaries above 18 years of age," a senior official said. Covaxin has been in the spotlight of controversy since it was recommended for restricted emergency use by the subject expert committee of CDSCO. It's approval for Covid immunization programme has drawn flak from public health advocacy groups, researchers, scientists and activists in the <keyword id="54611" type="PERSON" weightage="20" keywordseo="domain">domain</keyword>. The concern with the Coxaxin largely remains on its approval without the data from phase III clinical trials which determine efficacy of the drug. So far, any data proving the vaccine's efficacy has not been published in the public domain, including any results of an interim analysis. Meanwhile, a series of allegations involving violation of various protocols of human clinical trials have been put forth by trial volunteers of Covaxin in Bhopal's People's Medical College and Hospital, one of the 26 clinical trial sites of the Bharat Biotech's vaccine's phase III trials. Trial participants in Bhopal, who, incidentally, are also victims of the 1984 gas tragedy, have alleged "severe violations" of the model code of conduct pertaining to trials including absence of consent and no follow-up on their health after developing adverse reactions post the first dose by a particular clinical trial site. Notably, a 45-year-old trial participant in Bhopal also died nine days after he got the first jab at the People's Hospital, on December 21. However, Bharat Biotech, in a statement, said that the death had been "thoroughly investigated" and was found "not related to vaccine or placebo". The Madhya Pradesh government panel, too, ruled out any "lapses" from the hospital in the death case. --IANS str/rt

Covaxin: Government disapproves authorisation of Bharat Biotech's Covid vaccine to those below 18 years

<ul><li>You can now book a <keyword id="11352915" type="General" weightage="20" keywordseo="covid-19-vaccine-slot" source="Orion">COVID-19 vaccine slot</keyword> using WhatsApp.</li><li>The MyGov Corona helpdesk allows registered users to book vaccine slots.</li><li>You can follow the below steps to book a <keyword id="8904563" type="General" weightage="20" keywordseo="covid-19-vaccine" source="Orion">COVID-19 vaccine</keyword> slot near your home.</li></ul>The MyGov Corona helpdesk which was <a href="https://www.businessinsider.in/india/news/indian-govt-launches-mygov-coronavirus-helpdesk-on-whatsapp-to-educate-citizens/articleshow/74727460.cms">launched</a> to educate people about COVID-19 earlier this month received an update that enabled users to download their <a href="https://www.businessinsider.in/tech/news/how-to-get-covid-19-vaccination-certificate-on-whatsapp/articleshow/85176423.cms">vaccination certificate</a> using WhatsApp. Now, users will also be able to find their nearest vaccination center and book a slot. The MyGov Corona WhatsApp chatbot allows users to book both first and second shots. As per WhatsApp CEO <a href="https://twitter.com/wcathcart/status/1429987646370062338">Will Cathcart</a>, over 3 million people have downloaded their vaccine certificate using WhatsApp. Abhishek Sing, CEO of MyGov <a href="https://twitter.com/abhish18/status/1429869709122424838">announced</a> the launch of the new feature on Twitter. “Now book vaccination slot by simply sending ‘Book Slot’ to MyGovIndia Corona Helpdesk on WhatsApp, verify OTP &amp; follow the steps. Grateful to WhatsApp &amp; Haptik for their continued support to build this chatbot.”, he tweeted. Do note that this will work only if you have already registered on CoWin. How to book COVID-19 vaccine slot using WhatsApp <ol><li>To begin, you need to either save the MyGov Corona helpdesk number – 9013151515 on your phone or click on this <a href="https://api.whatsapp.com/send/?phone=919013151515&amp;text&amp;app_absent=0">link</a>. </li><li>Now, send the message ‘Book Slot’ and a six-digit OTP will be sent to your number. </li><li>Enter the six-digit OTP in the chat. </li><li>Now, select the person for whom you want to book a vaccine slot. </li><li>The chatbot will then show you the nearby centres based on the pincode and vaccine selected. </li><li>You can now select the preferred date and location. </li></ol>You will now receive a confirmation message for your COVID-19 vaccination slot. SEE ALSO: <a href="https://www.businessinsider.in/tech/apps/news/whatsapp-adds-a-payment-shortcut-so-you-can-send-money-faster-than-ever-before/articleshow/85589253.cms">WhatsApp adds a payment shortcut so you can send money faster than ever before</a> <a href="https://www.businessinsider.in/tech/news/how-google-forms-whatsapp-are-helping-afghans-with-resettlement-programs/articleshow/85421485.cms">How Google Forms, WhatsApp are helping Afghans to cross borders with resettlement programs</a> <a href="https://www.businessinsider.in/tech/apps/news/whatsapp-chat-transfer-feature-is-now-rolling-out-in-beta/articleshow/85392271.cms">WhatsApp’s iOS to Android chat transfer feature begins rolling out</a>

You Searched For "corona vaccine or 5 year old" and got 10 results

Pfizer's COVID-19 vaccine may be authorised for kids aged 5-12 by October, says company's board member

IANS

China's Sinovac vaccine is 50.7% effective against COVID-19, just reaching the threshold to be a vaccine worth using, a major trial showed

Dr. Catherine Schuster-Bruce

The first man to receive Pfizer's COVID-19 vaccine outside clinical trials is an Englishman named William Shakespeare, and the internet is having a field day

Bill Bostock

The 7 countries where kids under 5 years old are eligible for COVID-19 vaccines, and how the roll-outs are shaping up

Andrea Michelson,Mia de Graaf

Best learning toys for 5-year old kids

BI India Bureau

COVID-19 vaccine latest updates: Sinovac’s CoronaVac safe, early trial results show that vaccine triggers immune response

BI India Bureau

Here’s how to get COVID-19 vaccination certificate on WhatsApp

Shadab Rabbani

COVID-19 vaccine latest updates: Spain approves phase III trials of J&J vaccine, Feluda test kit for COVID to be launched in Delhi

BI India Bureau

Covaxin: Government disapproves authorisation of Bharat Biotech's Covid vaccine to those below 18 years

IANS

Here’s how to book COVID-19 vaccine slot using WhatsApp

Rounak Jain

Popular Keywords

Buying Guides